Gracell Biotechnologies Inc - ADR
GRCL
Market Cap$989.87M
Close$
Share Statistics
| Market cap | $989.87 Million |
|---|---|
| Enterprise Value | $-571,701,900.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-28.25 |
| Beta | -0.35 |
| Outstanding Shares | 16,784,936 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.6 |
|---|---|
| PEG | 4.29 |
| Price to Sales | - |
| Price to Book Ratio | 0.11 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.99 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.2 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Gracell Biotechnologies Inc
2,020 employeesGracell Biotechnologies Inc. (